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Abstract
Objective: To reviewand update the conceptual framework, indicator content and research priorities
of the Organisation for Economic Cooperation and Development’s (OECD) Health Care Quality Indi-
cators (HCQI) project, after a decade of collaborative work.
Design: A structured assessment was carried out using a modiﬁed Delphi approach, followed by a
consensus meeting, to assess the suite of HCQI for international comparisons, agree on revisions to
the original framework and set priorities for research and development.
Setting: International group of countries participating to OECD projects.
Participants: Members of the OECD HCQI expert group.
Results: A reference matrix, based on a revised performance framework, was used to map and as-
sess all seventy HCQI routinely calculated by the OECD expert group. A total of 21 indicators were
agreed to be excluded, due to the following concerns: (i) relevance, (ii) international comparability,
particularly where heterogeneous coding practices might induce bias, (iii) feasibility, when the num-
ber of countries able to report was limited and the added value did not justify sustained effort and (iv)
actionability, for indicators that were unlikely to improve on the basis of targeted policy interventions.
Conclusions: The revised OECD framework for HCQI represents a new milestone of a long-standing
international collaboration among a group of countries committed to building common ground for
performancemeasurement. The expert group believes that the continuation of this work is paramount
to provide decision makers with a validated toolbox to directly act on quality improvement strategies.
Key words: conceptual framework, health policy, health systems research, OECD Health Care Quality Indicators project,
performance measurement, quality indicators
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Introduction
Health care quality is a core dimension of health system performance
within which reliable standardized indicators have become increasing-
ly available [1, 2]. Originally developed with the aim of improving
patient outcomes in speciﬁc health care settings, health care quality
indicators now yield comparative information to be used for monito-
ring, management and policy making within and across health care
systems [3–6].
Under the umbrella of the Organisation for Economic Coope-
ration and Development (OECD), the ‘Health Care Quality Indicators’
(HCQI) Project was initiated in 2001, with the aim of developing and
reporting common indicators for international comparisons of health
care quality [7]. The general objective was to help Member States (MS)
identify priority areas for quality improvement and to provide an
indication of achievable standards by examining results among best
performing countries.
In 2006, the OECD released a common conceptual framework for
health system performance, within which the core quality dimension
was envisaged as a nested matrix, including an initial list of candidate
indicators under the vertical dimensions of ‘effectiveness’, ‘patient
safety’ and ‘responsiveness/patient-centeredness’ [8].
Consistent with the conceptual framework released by the US In-
stitute of Medicine [9], such dimensions were horizontally subdivided
according to levels of health care needs over the life cycle: ‘staying
healthy’ for healthy subjects, ‘getting better’ for people affected by a
disease, ‘living with illness or disability’ for those living with a chronic
condition and ‘coping with end of life’ for terminal patients. Since
then, the quality matrix had been used to deﬁne the scope of the
HCQI project without further revision.
Over the past decade, an ongoing activity of data collection and
statistical analysis has been carried out, progressively expanding the
coverage of the matrix and the number of countries involved. Coordi-
nation andmanagement of the process has been ensured bya continuous
dialogue between a central OECD secretariat and a representative group
of HCQI experts from OECD and non-OECD countries, international
organizations including the World Health Organization and the
European Commission and other relevant collaborating institutions,
including universities, subject matter experts and research organizations.
Since 2007, results of the HCQI project have routinely contributed
to international comparisons through the publication of the OECD
series ‘Health at a Glance’ [10] and the release of OECD Health Sta-
tistics alongside other international health data on expenditure, re-
sources, utilization and outcomes.
In 2013, the OECD HCQI data collection process included a total
of 70 indicators covering the following ‘themes’: Primary Care (PC);
Acute Care (AC); Mental Health (MH); Cancer Care (CC); Patient
Safety (PS) and Patient Experiences (PEs). The collection reports
data from 34 countries, including non-OECD member countries
such as Singapore and Latvia [11].
Alongside the regular data collection, there has been a concerted
research and development (R&D) effort to continuously improve
the deﬁnitions and availability of quality indicators for the inter-
national comparability of results achieved by health care systems.
New indicators have been pilot tested and data speciﬁcations included
in a reference guide used to instruct the global data collection [12]. A
common goal for the HCQI program of work was also strengthening
the national information infrastructure to produce more complex and
reliable indicators in an increasing number of countries [13, 14].
During recent years, the production of performance reports using
standardized HCQI deﬁnitions has continued to increase at the
international, national and subnational level [15–19]. Despite these
successes, following the completion of the 2013 OECD data collection,
it was evident that the data collection methodology was becoming more
complex and demanding on countries and that the growing numbers of
indicators and participating countries was placing additional burden on
the coordination and management of the project. Moreover, HCQI
experts generally agreed that more attention to the choice of indicators
and R&D studies was needed, including prioritizing indicators that
have proven to be reasonably ‘actionable’ by decision makers to
improve quality of care and health outcomes.
The present paper summarizes the results obtained to respond to
the following questions:
• Is the OECD conceptual framework for the HCQI still relevant?
• How to allocate each indicator to a unique position in its structure?
• What are the essential criteria to adopt future HCQI?
• Using deﬁned assessment criteria, which indicators should be re-
tained or dropped from the set of indicators, and how often should
they be measured?
• Which research and development activities are needed to improve
the international comparability of HCQI?
This paper reports the results of the framework review and the critical
appraisal of the indicators undertaken to respond to the questions
above, as well as the structure and content of the revised OECD frame-
work agreed by the Expert Group, and the set of research and deve-
lopment (R&D) activities endorsed by the Health Committee of the
OECD.
Methods
The study design was based on a modiﬁed Delphi procedure, which
included a review of the evidence on quality indicators conducted by
a panel of ﬁve experts, two rounds of ratings according to predeﬁned
criteria and a ﬁnal consensus meeting. The study was conducted
between May and November 2013.
Initially, all HCQIwere allocated to the original OECD conceptual
framework, according to the themes that historically guided indicator
development within the project (e.g. MH, CC and PC).
A Delphi data collection sheet was developed, comprising a set of
standardized worksheets, one for each theme, through which a small
panel of ﬁve experts independently scored each indicator according
to six criteria (Table 1). Scores were expressed on a Likert scale of
agreement, ranging from 1 to 9 (strongly disagree to strongly agree).
Additional columns requested expert opinion on: (i) whether to keep
and report regularly, keep and report less frequently, or drop the
indicator from future OECD HCQI data collections; (ii) degree of
priority for R&D to improve international comparability of the
indicators (ﬁve-point scale, very low to very high) and (iii) optional
comments. Indicators routinely reported as part of the HCQI project
but not included in the data collection (e.g. childhood and inﬂuenza
vaccination rates) were excluded from the questionnaire.
Although relevancewas used as a gating criterion for the inclusion/
exclusion of indicators, ratings were requested for all criteria to under-
pin the calculation of averages and the discussion/modiﬁcation of
initial scores.
Ratings were revised in person at a one-day meeting, organized to
(i) undertake a critical review of the full set of indicators currently
available at the HCQI, (ii) identify an agenda for future R&D work
and (iii) develop a set of recommendations for the broader expert
group.
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These recommendations were discussed at a ﬁnal consensus mee-
ting, where the broader HCQI expert group agreed on: (i) indicators
that should be kept or omitted from future HCQI data collections
and (ii) priorities for a future R&D agenda on indicators of quality
of care.
Results
The HCQI Expert Group agreed that the 4 × 3 quality matrix repre-
sented the appropriate scope for the project.
The revised structure of the broad OECD conceptual framework
within which the HCQI is included is presented in Fig. 1.
Minor changes to the original structure were agreed upon:
• change thewording of ‘staying healthy’ to ‘primary/secondary pre-
vention’ to provide a clearer distinction with ‘living with illness
and disability—chronic care’
• include the categories of ‘individual patient experiences’ and ‘inte-
grated care’ under the theme of ‘responsiveness’, to pave the
ground for future indicator development
Scores agreed by the panel are shown in Table 2. On average, the
Delphi panel scored relevance, actionability and validity higher than
reliability, international feasibility and comparability, recommending
omission for 25 indicators. The panel suggested dropping six indica-
tors from each of the groups of PS and PEs, while recommending to
retain all three CC indicators.
For indicators recommended for retention, the average scores ran-
ged between 5.4 (PEs) and 7.4 (CC). For ‘omit’ indicators, average
scores ranged between 5.3 (PEs) and 6.7 (PS).
In terms of relevance, scores were generally very high, with the
notable exception of indicators in the area of PEs, e.g. ‘difﬁculty to
travel’ (considered too generic as a question to patients), and ﬁve
more indicators related to waiting times and cost (perceived to be
more relevant for ‘access’).
Lower relevance and validity scores were allocated to indicators
that were more likely to capture differences among local clinical prac-
tices and way of organizing health care services, rather than aspects of
quality of care. On this basis, MH readmissions indicators were
dropped considering the varying roles of hospitals in disease manage-
ment across countries.
Both relevance and reliability led to omitting paediatric PS indica-
tors, considered to bemore likely reﬂecting quality issues for overall PS
rather than the speciﬁc target population.
Similarly, low reliability and feasibility scores were attributed to
indicators where regularly collected data were limited (e.g. retinal
examination in diabetes for which only ﬁve countries provided data
in 2013) or where not all required data elements were consistently
available (e.g. hip fracture surgery within 48 h, where there is
cross-country variation in recording the exact time of surgery).
Exclusion was also recommended when the uniform application of
standardized deﬁnitions was considered difﬁcult, e.g. accidental
puncture and postoperative haemorrhage or haematoma, or could
easily lead to a very small numbers of adverse events, e.g. paediatric
safety indicators.
Further R&Dwas recommended for indicators considered border-
line under the same criteria: (i) exploring the reasons of large variation
in surgery within 48 h after hip fracture, (ii) use of different deﬁnitions
or proxies of in-patient suicide in MH, (iii) impact of data capturing
systems on excess mortality inMH and (iv) heterogeneous approaches
to CC measurement.
In terms of actionability, lower average scores were assigned to
hypertension hospital admission in PC, in-hospital mortality in AC,
all indicators excluded from PS (except for retained surgical item)
and waiting time on day of consultation, consultation skipped due
to difﬁculties in travelling in PEs. In these cases, the panel agreed
that it was difﬁcult for policy makers to identify immediate solutions
that would counteract underperforming results.
International feasibility oriented choices towards a sustainable
data collection. Three case-fatality indicators for events occurring ‘in
any hospital’ were dropped, as they were regarded as adding little
value to the other six mortality indicators already present in the frame-
work. All in-hospital indicators for the ‘same hospital’ were recom-
mended for retention, due to their large degree of availability.
In terms of international comparability, a major concern was ex-
pressed for different coding practices, particularly for diagnoses and
medical procedures. Hospital admissions for hypertension were
dropped for the likely under-reporting of conditions recorded as prin-
cipal diagnosis. Similar concerns were expressed for cross-country
variation in the recording of secondary diagnoses, which can impact
on the accuracy of indicators in given performance domains, e.g. PS.
Moreover, the panel suggested to pool indicators on diabetes admis-
sions with and without complications and to carefully revise the def-
inition of lower amputations, recognizing cross-country differences in
coding and data capture for these indicators.
Improved comparability was at the basis of many recommendations
for R&D.
In relation to coding, the panel recommended investigating the
following: role of primary and secondary diagnosis, different deﬁnitions
of admissions/discharges, use of transfers and criteria to map indicators
across ICD9–10. Other activities suggested include deﬁning composite
measures for PC indicators, assessing indicators of pharmaceutical
prescriptions, reporting of secondary diagnoses in PS indicators,
statistical methods and national representativeness of CC indicators
and sampling methods and validated deﬁnitions of ‘doctor’ and
‘regular doctor’ in PE surveys.
Table 1 Criteria used to score HCQI
Criterion Deﬁnition
Validity Sufﬁcient scientiﬁc evidence exists to support a
link between the value of an indicator and one
or more aspects of health care quality
Reliability Repeated measurements of a stable phenomenon
get similar results
Relevance An indicator measures an aspect of quality with
high clinical importance, a high burden of
disease or high health care use
Actionability An indicator measures an aspect of quality that is
subject to control by providers and/or the
health care system and is actually used at a
national level for policy making, monitoring or
strategy development
International
feasibility
An indicator can be derived for international
comparisons without substantial additional
resources
International
comparability
Reporting countries comply with the relevant
data deﬁnition and where differences in the
indicator values between countries reﬂect issues
in quality of care rather than differences in data
collection methodologies, coding or other
non-quality of care reasons
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Final average scores for all indicators and all criteria included in
the questionnaire are reported along with the number of experts sup-
porting retention and prioritization of R&D in Table A1 in Appendix.
The ﬁnal consensus meeting adopted all recommendations made
by the Delphi panel, with the only exception of four indicators of
PEs previously moved to ‘access’, which were reintegrated into the
quality dimension (waiting time on the day of appointment, consul-
tation skipped due to costs, medical tests, treatment or follow-up
skipped due to costs and prescribed medicines skipped due to costs).
Six additional prescription safety indicators obtained from a previous
study were also added [20].
The ﬁnal allocation of each indicator to a unique position in the
4 × 3 quality matrix is shown in Table 3, including (i) indicators re-
tained for the 2015 data collection (in plain bold), (ii) indicators in-
cluded in the framework, but not part of the routine biennial data
collection (in italic) and (iii) dropped indicators (in plain text). The
Figure 1 Revised OECD framework for performance measurement.
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content of the matrix presents a triangular pattern with an empty row
at the bottom. Among vertical dimensions, the one most covered is ‘ef-
fectiveness’, followed by ‘safety’ and ‘responsiveness’. The horizontal
dimension of ‘coping with end of life’ is still empty for international
comparisons.
The classiﬁcation allowed for different themes to ﬁt into the same
cell in the matrix (e.g. ‘living with illness’). However, experts noted
that for several indicators more than one domain could be considered
along one or both axes depending on the context. For example: pre-
scribing indicators for antibiotics may fall under ‘effectiveness’ (i.e.
high rates reﬂect prescription beyond indication or inappropriate/inef-
fective use) or ‘safety’ (i.e. high rates may affect future resistance);
hypertension may fall under ‘primary or secondary prevention’ or ‘li-
ving with illness’ depending on whether it is viewed as a modiﬁable
risk factor for future disease development or as a disease; obstetric
trauma as a safety indicator may equally ﬁt under the health care
needs category of preventive intervention or under ‘getting better’;
PEsmay provide responses on visits done by healthy subjects or people
with chronic diseases.
In the ﬁnal mapping, allocations were based on expert agreements
on the most prevalent contextual interpretation for each indicator.
However, experts advised that the multi-dimensional nature of
many HCQI shall be given adequate consideration in the interpreta-
tion of the results.
Discussion
This critical appraisal produced international consensus on the revised
structure and content of the OECD framework for HCQI.
Overall, agreement was reached on omitting 21 and retaining 49
indicators of those included in the 2013 data collection. The amalga-
mation of diabetes indicators and the further addition of prescription
safety indicators lead to a total of 53 indicators, plus additional 9 in-
dicators collected by other means, for a total of 62 indicators foreseen
for data collection and publication in 2015.
The appraisal offered a unique opportunity to bridge past achieve-
ments with the resolution of current challenges in the international
comparison of health systems.
The results achieved can be seen as a concerted response to resol-
ving the challenges in the international comparisons of health systems,
building upon principles described elsewhere as sets of ‘must do’s’ and
‘trade-offs’ [4].
For ‘must do’s’, the appraisal provided a way forward to reinforce
the ‘legitimacy’, ‘validity’, ‘feasibility’ and ‘technical support’ in the
production of international comparisons of quality of care for
OECD countries.
The process adopted for the choice of indicators reinforced ‘legi-
timacy’ through shared coordination, producing recommendations
as a result of an open dialogue among peers, including a total of 57
international experts representing the countries participating in the
project. The agreed R&D plan was jointly developed and tasks as-
signed on the basis of voluntary contribution of MS.
Notably, the Delphi panel relied on higher scores for established
criteria, e.g. relevance and validity for the initial choice of items re-
tained in the revised framework. This is not surprising, because indi-
cators that are part of the OECD data collection have stood up to
scientiﬁc testing at the national level. The choice of including indica-
tors that are still difﬁcult to collect, e.g. 30-day in and out of hospital
mortality in AC or death after discharge and excess mortality in MH,
while excluding MH readmissions that scored even better overall and
were reported by many countries, reﬂects the level of priority assigned
by HCQI experts to such fundamental criteria.
However, the fact that actionability stood as the second highest cri-
terion met by all quality indicators shows that other practical criteria
are equally important to identify a core suite that ﬁts the needs of
policy makers. This criterion clearly oriented the choices for retention
in the areas of AC and PS.
The criteria of reliability, international comparability and feasibi-
lity oriented further discussions on the omission of indicators and
R&D based on the practical experience of the HCQI data collection.
In PC, issues of reliability were at the basis of the omission of
hospital admission for hypertension and retinal exam for people
with diabetes. A total of six PS indicators were recommended for omis-
sion, due to either an extremely low volume of cases (paediatric) or
difﬁcult applicability of the deﬁnitions and/or inconsistent coding
across countries (accidental puncture, postoperative haemorrhage or
haematoma).
Improving the reliability, feasibility and comparability of indica-
tors is at the core of the cross-cutting R&D agenda agreed by the
Expert Group.
One aspect that was recognized to be overtly important was sys-
tematic variation in coding practices. For example, payment systems
that provide a higher payment for more complicated cases may create
an incentive for hospital administrators to ensure that secondary
Table 2 Average scores assigned by the Delphi panel for each criterion used to review indicators included in the HCQI 2013 data collection, by
theme and recommendation for future data collection
Criterion PC AC MH CC PS PEs Overall
Keep
(N = 13)
Drop
(N = 2)
Keep
(N = 7)
Drop
(N = 3)
Keep
(N = 6)
Drop
(N = 8)
Keep
(N = 3)
Drop
(N = 0)
Keep
(N = 8)
Drop
(N = 6)
Keep
(N = 8)
Drop
(N = 6)
Relevant 6.9 6.7 7.5 7.0 7.3 6.7 8.2 7.6 7.7 6.6 4.4 7.1
Valid 6.8 6.4 6.8 6.3 6.5 5.9 8.0 7.3 6.8 5.4 5.7 6.5
Reliable 6.7 5.3 7.2 7.1 5.2 6.6 7.4 6.3 5.2 5.0 5.1 6.1
Actionable 6.7 6.4 7.2 7.2 5.9 6.0 7.4 7.9 7.5 5.8 5.9 6.6
Internationally
feasible
6.2 5.5 6.5 6.2 4.8 6.3 7.0 7.0 6.7 4.8 5.2 6.0
Internationally
comparable
6.0 4.8 6.2 5.6 5.5 5.6 6.4 6.2 6.1 5.0 5.1 5.7
Overall 6.6 5.8 6.9 6.6 5.9 6.2 7.4 7.0 6.7 5.4 5.3 6.3
Keep = keep and publish regularly, keep and publish less regularly; drop = omit from future OECD HCQI data collection; N = number of indicators falling in each
subcategory.
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Table 3 Results of the mapping of OECD HCQI to the revised conceptual frameworka
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diagnoses are widely captured, or countries consistently reporting a
higher number of secondary diagnoses are likely to capture more ad-
missions for speciﬁc indicators, particularly in PS [21]. A related case
is coding at different phases of episodes of care, particularly in hospi-
talizations. In the HCQI guidelines, the terms ‘discharge’, ‘admission’
and ‘separation’ have been considered interchangeable to allow wider
adherence to the data collection, based on local practices. However, it
is possible that results for countries using diagnostic codes at one stage
may vary considerably from those recording at other stages.
To explore the effect of these issues on several indicators, the broad
group agreed to launch a series of targeted studies, using common pro-
tocols across volunteering countries.
The provision of adequate ‘technical support’ for data correspon-
dents is a direct consequence of increased attention to methodological
aspects. With increasing complexity, and the prospective challenge of
covering all dimensions of the performance framework, it is important
that the data collection process proceeds as efﬁciently as possible. Tar-
geted IT tools can be used to harmonize the application of standard
guidelines and to reduce the chance of uneven compliance, e.g. a cen-
tral repository of electronic meta-data instead of paper guidelines, the
sharing of open-source statistical software for the direct calculation of
HCQI and common policies for data exchange are recommended.
In terms of trade-offs, this study highlighted the importance of
balancing ‘depth and breadth’, ‘aggregation and granularity’ and
‘ﬂexibility and consistency’ when reporting on HCQI. Among these
trade-offs, a discussion on the dichotomy between ‘depth’ and
‘breadth’ (i.e. more measures for a speciﬁc clinical area vs. measures
for a greater variety of clinical areas) was central to reviewing the map-
ping of indicators to the conceptual framework and led to the identi-
ﬁcation of areas in need of further indicator development and
reporting, e.g. ‘getting better’ for responsiveness, ‘living with illness’
in safety and responsiveness, long-term care and end of life across
all dimensions. These aspects have been duly marked for targeted
action.
The decision to pursue indicators related to ‘in and out of hospital’
mortality in AC and excess mortality in MH reﬂects MS interest in im-
proving the availability of clinical outcomes. Trends in the HCQI data
collection show that data collection for these indicators is becoming
increasingly feasible among MS, indicating that the health informa-
tion infrastructure is improving. For example, between 2007 and
2013, the number of countries able to report the 30-day mortality
rate in and out of hospital for the last year available, requiring linking
hospital admissions and death records, increased from 12 to 16 [11,
12].
Increased ‘depth’ has also been requested for comparisons of PEs,
such as exploring how organizational aspects improve clinical path-
ways through integrated and continuous care. While these tasks may
draw upon innovative performance measurement approaches, e.g. the
work in the UK on Patient Reported Outcome Measures (PROMs), it
will need targeted attention on articulated concepts, e.g. integrated
and coordinated care across health, social, long-term and home
care, taking relevant experiences into account [22].
The broad group also agreed to extend the applicability of HCQI
at provider level in 2015, particularly at hospital level.
The issue of ‘aggregation vs. granularity’ particularly applies to the
decision to pilot test composite measures for hospital admissions, such
as a composite indicator for asthma, COPD, CHF and diabetes
hospital admissions.
The trade-off between ‘consistency’ and ‘ﬂexibility’ has been
tackled by an ambitious R&D agenda, including targeted work on im-
proved deﬁnitions to ensure comparability at all levels. In some cases,
it would require identifying ﬂexible solutions that can be applied
under different conditions. A speciﬁc case of consistency failure is
deep vein thrombosis in speciﬁc surgeries, where attempting to specify
a precise set has in fact led to greater difﬁculty in achieving internatio-
nal comparability, rather than less as intended.
An increased attention for the principle of ‘actionability’ has been
called upon to orient future activities, based on experts’ recommenda-
tions to further uptake HCQI outputs in health systems performance
assessment. To this end, the broad group agreed to support an initial
survey on experiences on using HCQI (producers, methods and re-
porting schemes) at both national and subnational level, to monitor
the actual usage of the framework and indicators over time.
Finally, intrinsic limitations of the present appraisal are worth
outlining.
The conclusions are based on a Delphi panel of limited size,
moderated by the same secretariat coordinating the HCQI project,
whose ﬁnal recommendations were produced by a broad group, in-
cluding experts and representatives of national governments.
A different multidisciplinary setting, composed of a larger pool of
experts completely independent from governmental institutions, may
likely lead to different results. However, the completely open, trans-
parent and well-structured process put in place by the OECD with
the direct participation of MS assures that these results can represent
the best possible combination for governments wishing to commit to
international comparisons of quality of care.
In conclusion, this appraisal delivered a revised OECD framework
for HCQI, a revised set of indicators and a plan for further improve-
ment. A number of countries have already indicated a willingness to
work together on moving forward the rich international R&D agenda
outlined in this paper. The results of this work will be reﬂected in fu-
ture strategies aimed at improving the international comparability of
quality indicators in years to come. Such continuous improvements in
the datawill hopefully lead tomore rigorous debates about how policy
makers can plan effective action to improve health system perfor-
mance for the direct beneﬁt of all citizens.
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Table A1 Results of the Delphi Panel for all HCQI included in the 2013 data collection: average scores for all criteria included in the questionnaire and number of responses for retention and
prioritization of R&D
Area Description Valid Reliable Relevant Actionable Internationally
feasible
Internationally
comparable
Recommend to
keepa
Medium/high
R&D prioritya
PC Asthma hospital admission 7.4 7.2 7.6 7.4 7.6 7.2 5 3
PC COPD hospital admission 7.4 7.4 7.6 7.2 7.6 7.0 5 2
PC CHF hospital admission 6.8 7.6 7.2 7.0 7.6 7.0 4 1
PC Hypertension hospital admission 6.2 5.6 5.8 5.6 7.0 5.0 3 4
PC Uncontrolled diabetes without complications hospital admission 7.4 5.8 6.6 6.4 7.0 5.8 5 4
PC Diabetes short-term complications hospital admission 7.4 7.2 7.6 7.4 7.4 7.0 5 3
PC Diabetes long-term complications hospital admission 7.4 7.0 7.6 7.2 7.4 6.6 5 3
PC Diabetes lower extremity amputation 7.6 7.0 7.6 6.2 7.2 6.2 5 4
PC Annual retinal exam for diabetics 6.6 5.0 7.6 7.2 4.0 4.6 3 4
PC Adequate use of cholesterol lowering treatment in diabetic patients (DDDs) 5.4 5.4 5.2 5.4 4.4 4.4 2 3
PC First choice antihypertensives for diabetes patients (DDDs) 5.4 5.4 5.4 5.4 4.4 4.4 3 3
PC Long-term use of benzodiazepines and benzodiazepine-related drugs in the elderly 7.0 6.8 7.2 7.0 5.0 5.4 4 4
PC Use of long-acting benzodiazepines in elderly patients 7.0 6.8 7.2 7.0 5.0 5.4 4 4
PC Overall volume of antibiotics for systemic use prescribed (DDDs) 6.4 6.8 6.6 6.8 5.2 5.6 4 4
PC Volume of cephalosporines/quinolones as a proportion of all systemic antibiotics prescribed (DDD) 6.4 6.8 6.8 6.8 5.2 5.4 3 3
AC Patient-based AMI 30-day (in-hospital and out of hospital) mortality 8.2 7.8 8.2 7.6 5.8 6.2 5 3
AC Patient-based AMI 30-day in-hospital (any hospital) mortality 6.4 7.2 7.0 7.2 6.2 5.6 2 4
AC Admission-based AMI 30-day in-hospital mortality (same hospital) 5.8 6.8 6.8 6.8 7.0 6.0 4 2
AC Patient-based haemorrhagic stroke 30-day (in-hospital and out of hospital) mortality 8.0 7.8 8.2 7.6 5.8 6.2 5 3
AC Patient-based haemorrhagic stroke 30-day in-hospital (any hospital) mortality 6.2 7.0 7.0 7.2 6.2 5.6 2 4
AC Admission-based haemorrhagic stroke 30-day in-hospital mortality (same hospital) 5.6 6.6 6.8 6.8 7.0 6.0 4 2
AC Patient-based ischaemic stroke 30-day (in-hospital and out of hospital) mortality 8.0 7.6 8.2 7.6 5.8 6.4 5 3
AC Patient-based ischaemic stroke 30-day in-hospital (any hospital) mortality 6.2 7.0 7.0 7.2 6.2 5.6 2 4
AC Admission-based ischaemic stroke 30-day in-hospital mortality (same hospital) 5.6 6.6 6.8 6.8 7.0 6.0 4 2
AC Hip-fracture surgery initiated within 48 h after admission to the hospital 6.6 7.4 7.2 7.4 7.0 6.8 4 3
MH Any hospital readmissions within 30 days for patients discharged with schizophrenia 6.0 6.8 6.8 5.4 6.2 5.6 2 1
MH Same hospital readmissions within 30 days for patients discharged with schizophrenia 5.4 6.8 6.4 5.4 6.2 5.4 2 1
MH Any hospital readmission within 30 days among patients discharged with schizophrenia 6.4 6.6 7.0 6.6 6.4 5.8 4 3
MH Same hospital readmission within 30 days among patients discharged with schizophrenia 5.8 6.6 6.6 6.6 6.4 5.6 4 3
MH Any hospital readmissions within 30 days for patients discharged with bipolar disorder 6.0 6.6 6.8 5.4 6.2 5.6 2 1
MH Same hospital readmissions within 30 days for patients discharged with bipolar disorder 5.4 6.6 6.4 5.4 6.2 5.4 2 1
MH Any hospital readmission within 30 days among patients discharged with bipolar disorder 6.4 6.4 7.0 6.6 6.4 5.8 4 3
MH Same hospital readmission within 30 days among patients discharged with bipolar disorder 5.8 6.4 6.6 6.6 6.4 5.6 4 3
MH In-patient suicides among people diagnosed with a mental disorder 6.0 4.4 7.0 6.4 4.8 5.2 4 3
MH In-patient suicides among people diagnosed with schizophrenia or bipolar disorder 6.0 4.4 7.0 6.4 4.8 5.2 4 3
MH Deaths after discharge from suicide among people diagnosed with a mental disorder 6.4 5.0 7.0 5.2 4.4 5.2 5 4
MH Deaths after discharge from suicide among people diagnosed with schizophrenia or bipolar disorder 6.4 5.0 7.0 5.2 4.4 5.2 5 5
MH Excess mortality for patients with schizophrenia 7.2 6.2 7.8 6.0 5.2 6.2 5 4
MH Excess mortality for patients with bipolar disorder 7.2 6.2 7.8 6.0 5.2 6.2 5 4
CC Breast cancer 5-year relative survival 8.0 7.4 8.2 7.4 7.0 6.4 5 3
CC Cervical cancer 5-year relative survival 8.0 7.4 8.2 7.4 7.0 6.4 5 3
CC Colorectal cancer 5-year relative survival 8.0 7.4 8.2 7.4 7.0 6.4 5 3
PS Retained surgical item or unretrieved device fragment (paediatric) 7.6 4.6 8.0 8.2 7.4 6.2 4 4
PS Retained surgical item or unretrieved device fragment (adult) 7.6 5.2 8.2 8.2 7.8 6.4 5 4
PS Accidental puncture or laceration (paediatric) 6.6 5.0 7.6 7.2 7.2 6.6 4 4
PS Accidental puncture or laceration (adult) 6.6 6.4 7.8 7.2 7.6 6.6 4 5
PS Postoperative haemorrhage or haematoma (paediatric) 6.4 4.6 7.5 7.5 6.0 5.6 3 4
PS Postoperative haemorrhage or haematoma (adult) 6.4 5.4 7.6 7.6 6.2 5.6 3 4
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Table A1 Continued
Area Description Valid Reliable Relevant Actionable Internationally
feasible
Internationally
comparable
Recommend to
keepa
Medium/high
R&D prioritya
PS Postoperative wound dehiscence (paediatric) 7.4 5.4 7.4 7.4 6.0 6.2 3 3
PS Postoperative wound dehiscence (adult) 7.4 6.4 7.6 7.4 6.2 6.2 3 4
PS Postoperative PE or DVT—all surgical discharges 6.4 5.8 6.8 7.4 6.8 6.4 5 4
PS Postoperative PE or DVT—hip and knee replacement discharges 7.4 5.6 8.0 8.2 6.6 5.8 4 5
PS Postoperative sepsis—all surgical discharges 7.0 7.0 6.6 8.2 7.2 7.0 5 3
PS Postoperative sepsis—abdominal discharges 7.4 7.0 7.4 8.2 6.8 6.4 4 4
PS Obstetric trauma vaginal delivery with instrument 7.2 6.4 8.0 7.6 7.4 5.6 5 5
PS Obstetric trauma vaginal delivery without instrument 7.8 6.8 8.0 7.6 7.4 5.6 5 5
PE Waiting time of >4 weeks for getting appointment with a specialist 5.8 5.0 6.0 6.0 4.8 4.8 3 3
PE Waiting time of >1 h on the day of consultation with a doctor 5.2 4.8 5.2 5.2 4.8 5.0 3 4
PE Consultation skipped due to difﬁculties in travelling 5.0 4.8 5.8 5.2 4.8 5.0 4 4
PE Consultation skipped due to costs 5.4 4.8 6.6 5.8 4.8 5.0 4 4
PE Medical tests, treatment or follow-up skipped due to costs 5.4 4.8 6.6 5.8 4.8 5.0 3 3
PE Prescribed medicines skipped due to costs 5.4 4.8 6.6 5.4 4.8 5.0 4 4
PE Doctor spending enough time with patients during the consultation 5.2 5.0 6.0 6.0 4.8 5.0 4 4
PE Regular doctor spending enough time with patients during the consultation 5.2 5.0 6.0 5.8 4.8 5.0 3 3
PE Doctor providing easy-to-understand explanations 5.6 5.0 7.0 5.8 4.8 5.0 4 4
PE Regular doctor providing easy-to-understand explanations 5.6 5.0 7.0 5.8 4.8 5.0 3 3
PE Doctor giving opportunity to ask questions or raise concerns 5.6 5.0 6.6 5.8 4.8 5.0 4 4
PE Regular doctor giving opportunity to ask questions or raise concerns 5.6 5.0 6.6 5.8 4.8 5.0 3 3
PE Doctor involving patients in decisions about care or treatment 5.2 5.0 6.6 5.8 4.8 5.0 4 4
PE Regular doctor involving patients in decisions about care or treatment 5.2 5.0 6.6 5.8 4.8 5.0 3 3
aNumber of responses over a maximum achievable of 5.
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